FBXL17 and medulloblastoma: Importantly, mutations in other components of Hh signaling pathway, such as Ptch (present in > 50% of SHH medulloblastoma) (Kool et al, 2014), will also affect Sufu protein levels, given the effect of pathway activation on Sufu protein mediated by Fbxl17.